Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (11): 5778-5788.doi: 10.11843/j.issn.0366-6964.2025.11.035

• Preventive Veterinary Medicine • Previous Articles     Next Articles

Construction and Immune Effect in Mice of Recombinant Pseudorabies Virus Expressing Porcine Circovirus Type 3 Cap Protein

SONG Ruoqi(), TAN Shanshan(), MA Ruiyi, CHEN Xinxin, YI Yue, MA Mengyao, WANG Ying, NIU Sheng, YAN Fang, ZHAO Yujun, TIAN Wenxia*(), REN Jianle*()   

  1. College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China
  • Received:2024-12-25 Online:2025-11-23 Published:2025-11-27
  • Contact: TIAN Wenxia, REN Jianle E-mail:1078331987@qq.com;409807042@qq.com;wenxiatian@126.com;renjianle0615@163.com

Abstract:

This study aimed to construct a viral vector vaccine expressing the Cap protein of porcine circovirus type 3 (PCV3). In this study, pseudorabies virus (PRV) SX1910 strain was designated as the parental strain. Using CRISPR/Cas9 and homologous recombination technologies, a recombinant virus SX1910-ΔgE/gI-GFP was constructed, which lacked the gE and gI genes and harbored a LoxP site and GFP fluorescent marker. Then, the GFP expression cassette of SX1910-ΔgE/gI-GFP was replaced with the double expression cassette of the PCV3 Cap gene by using Cre enzyme, generating the recombinant virus rSX1910-ΔgE/gI-2CapPCV3. Then its in vitro biological characteristics and immunological effects were analysed. The results showed that rSX1910-ΔgE/gI-2CapPCV3 exhibited significantly reduced in vitro replication capacity and plaque size compared to the parental strain SX1910. Preliminary evaluation of immunogenicity in 6-week-old female BALB/c mice demonstrated that rSX1910-ΔgE/gI-2CapPCV3 effectively stimulated the production of Cap protein-specific antibodies in mice, alleviated PCV3-induced lung tissue damage, and significantly reduced viral loads in tissues. Therefore, rSX1910-ΔgE/gI-2CapPCV3 can elicit a good immune response in mice, providing a scientific foundation for the development of novel vaccines for PCV3.

Key words: porcine circovirus type 3, Cap protein, pseudorabies virus, CRISPR Cas9, immune protection

CLC Number: